STAY IN THE KNOW

January 30, 2018

NESS-ZIONA, ISRAEL--(Marketwired - January 30, 2018) - VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative Israeli cancer immunotherapy company, is pleased to announce the closing of an oversubscribed equity financing of $1,810,000 (the "Financing").

INDIVA CORP. COMPLETES REVERSE TAKEOVER ACQUISITION AND CONCURRENT FINANCING

December 15, 2017

LONDON, Ontario, Dec. 15, 2017 (GLOBE NEWSWIRE) -- INDIVA Limited (the "Company", formerly Rainmaker Resources Ltd.) (TSX-V:NDVA) is pleased to announce it has  closed its previously announced acquisition of 100% of the issued and outstanding securities of Indiva Corporation ("Indiva") by way of a "three-cornered" statutory amalgamation of Indiva and a wholly-owned subsidiary of the Company (the "Acquisition"). The Company issued 43,540,000 Common Shares to the holders of securities of Indiva at an ascribed price of $0.75 per Common Share after giving effect to the Consolidation, for aggregate consideration of $32,655,000. 

INDIVA CORPORATION AND RAINMAKER RESOURCES LTD. CLOSE FIRST TRANCHE OF SUBSCRIPTION RECEIPT FINANCING

August 28, 2017

LONDON, Ontario and VANCOUVER, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) -- INDIVA Corporation ("Indiva" or the "Company") and Rainmaker Resources Ltd. ("Rainmaker") (TSX-V:RIR) are pleased to announce closing of the first tranche of the subscription receipt ("Subscription Receipt") financing of Rainmaker (the "First Tranche") previously announced in a press release issued on  June 1, 2017 (the "Offering"). In this First Tranche, Rainmaker issued 7,674,609 Subscription Receipts at a price of $0.75 per Subscription Receipt for aggregate gross proceeds of $5,755,956.75.  Indiva and Rainmaker have engaged Sunel Securities Inc. ("Sunel") to act as agent in connection with the Offering.

MEDICAL CANNABIS COMPANY INDIVA TO LIST ON TSX VENTURE EXCHANGE

June 01, 2017

INDIVA Corporation. ("INDIVA" or the "Company"), a London, Ontario based cannabis company focused on obtaining its Cultivation License pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"), today announced that it has signed a binding Letter of Intent with Rainmaker Resources Ltd. ("Rainmaker") (TSX VENTURE:RIR) pursuant to which the parties will complete a reverse takeover and change of business transaction (the "Transaction") on the TSX Venture Exchange (the "Exchange"). Sunel Securities has been engaged as lead agent and is expected to form a syndicate of investment banks to participate in the Offering.

Subscribe to receive updates.